CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease
CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease
复制标题
CD4( )CD25( )FoxP3( ) 调节性 T 细胞抑制活动性疾病患者的结核分枝杆菌免疫。
DOI:
10.1016/j.clim.2006.11.009
复制
发表时间:
2007-04-01
影响因子:
8.6
通讯作者:
Katsanis, Emmanuel
中科院分区:
文献类型:
--
作者:
Chen, Xinchun;Zhou, Boping;Katsanis, Emmanuel
CD4(+)CD25(+) regulatory T cells (Treg) play a central role in the prevention of autoimmunity and in the control of immune responses by down-regulating the function of effector CD4(+) or CD8(+) T cells. The role of Treg in Mycobacterium tuberculosis infection and persistence is inadequately documented. Therefore, the current study was designed to determine whether CD4(+)CD25(+)FoxP3(+) regulatory T cells may modulate immunity against human tuberculosis (TB). Our results indicate that the number of CD4(+)CD25(+)FoxP3(+) Treg increases in the blood or at the site of infection in active TB patients. The frequency of CD4(+)CD25(+)FoxP3(+) Treg in pleural. fluid inversely correlates with local MTB-specific immunity (p < 0.002). These CD4(+)CD25(+)FoxP3(+) T lymphocytes isolated from the blood and pleural fluid are capable of suppressing MTB-specific IFN-gamma and IL-10 production in TB patients. Therefore, CD4(+)CD25(+)FoxP3(+) Treg expanded in TB patients suppress M. tuberculosis immunity and may therefore contribute to the pathogenesis of human TB. (c) 2006 Elsevier Inc. All rights reserved.